| __timestamp | Celldex Therapeutics, Inc. | Corcept Therapeutics Incorporated |
|---|---|---|
| Wednesday, January 1, 2014 | 104381000 | 18372000 |
| Thursday, January 1, 2015 | 100171000 | 15419000 |
| Friday, January 1, 2016 | 102726000 | 23844000 |
| Sunday, January 1, 2017 | 96171000 | 40376000 |
| Monday, January 1, 2018 | 66449000 | 75247000 |
| Tuesday, January 1, 2019 | 42672000 | 89017000 |
| Wednesday, January 1, 2020 | 42534000 | 114764000 |
| Friday, January 1, 2021 | 53311000 | 113864000 |
| Saturday, January 1, 2022 | 82258000 | 130991000 |
| Sunday, January 1, 2023 | 118011000 | 184353000 |
Unleashing insights
In the competitive world of biotechnology, research and development (R&D) spending is a critical indicator of a company's commitment to innovation. Over the past decade, Corcept Therapeutics Incorporated and Celldex Therapeutics, Inc. have demonstrated contrasting trajectories in their R&D investments. From 2014 to 2023, Corcept's R&D expenses surged by over 900%, peaking in 2023 with a remarkable $184 million. In contrast, Celldex's R&D spending fluctuated, with a notable dip in 2019, before rebounding to $118 million in 2023. This divergence highlights Corcept's aggressive investment strategy, while Celldex's spending reflects a more variable approach. As the biotech industry continues to evolve, these spending patterns offer insights into each company's strategic priorities and potential future breakthroughs.
Research and Development Investment: AbbVie Inc. vs Celldex Therapeutics, Inc.
Comparing Innovation Spending: Pfizer Inc. and Corcept Therapeutics Incorporated
R&D Insights: How Neurocrine Biosciences, Inc. and Corcept Therapeutics Incorporated Allocate Funds
Intra-Cellular Therapies, Inc. or Celldex Therapeutics, Inc.: Who Invests More in Innovation?
Summit Therapeutics Inc. or Celldex Therapeutics, Inc.: Who Invests More in Innovation?
Research and Development Expenses Breakdown: Sarepta Therapeutics, Inc. vs Corcept Therapeutics Incorporated
Lantheus Holdings, Inc. or Corcept Therapeutics Incorporated: Who Invests More in Innovation?
Who Prioritizes Innovation? R&D Spending Compared for Corcept Therapeutics Incorporated and Bausch Health Companies Inc.
Research and Development: Comparing Key Metrics for Verona Pharma plc and Celldex Therapeutics, Inc.
Research and Development Investment: Apellis Pharmaceuticals, Inc. vs Celldex Therapeutics, Inc.
Analyzing R&D Budgets: Supernus Pharmaceuticals, Inc. vs Celldex Therapeutics, Inc.
Research and Development: Comparing Key Metrics for Wave Life Sciences Ltd. and Celldex Therapeutics, Inc.